Abstract
Headache is one of the most common complaints of patients seeking medical attention. There are several important indications to warrant investigation of a headache: a patient’s first or worst headache; a recent change in the patient’s headache pattern; new neurologic findings; no response to treatment; and symptoms that do not correspond to a primary headache such as migraine, tension-type, or cluster [1].
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Couch JR: Headache to worry about. Med Clin North Am 1993, 77: 141–167.
Rasmussen BK, Jensen R, Schroll M, Olesen J: Epidemiology of headache in a general population—a prevalence study. J Clin Epidemiol 1991, 44 (11): 1147–1157.
Lipton RB, Stewart WF: Migraine in the United States: a review of epidemiology and health care use. Neurology 1993, 43: S6 - S10.
Schwartz BS, Stewart WF, Simon D, Lipton RB: Epidemiology of tension-type headache. JAMA 1998, 279 (5): 381–383.
Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988, 7: 1–96.
Launer LJ, Terwindt GM, Ferrari MD: The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 1999, 53 (3): 537–542.
Stewart WF, Linet MS, Celentano DD, et al.: Age-and sex-specific incidence rates of migraine with and without aura. Am J Epidemiol 1991, 134:1111–1120.
S. Stewart WF, Lipton RB, Liberman J: Variation in migraine prevalence by race. Neurology 1996, 47 (1): 52–59.
Lipton RB, Stewart WF: Acute migraine therapy. Headache 1999, 39: S20 - S26.
Hu XH, Markson LE, Lipton RB, et al.: Burden of migraine in the United States: disability and economic costs. Arch Intern Med 1999, 159(8):813–818.
Terwindt GM, Ferrari MD, Tijhuis M, et al.: The impact of migraine on quality of life in the general population: the GEM study. Neurology 2000, 55:624–629.
Couch JR: Complexities of presentation and pathogenesis of migraine headache. In Treating the Headache Patient. Edited by Cady RK, Fox AW. New York: Marcel Dekker; 1995.
Lenaerts M: Migraine and epilepsy: comorbidity and temporal relationship. Paper presented at: Ninth Congress of the International Society; June 1999; Barcelona, Spain.
Merikangas KR, Merikangas JR, Angst J: Headache syndromes and psychiatric disorders: association and familial transmission. J Psychiatr Res 1993, 27: 197–210.
Olesen J, Tfelt-Hansen P, Welch KMA: The Headaches. New York: Raven Press; 1993: 256–266.
Lennox WG, Gibbs EL, Gibbs FA: Effect of ergotamine tartrate on the cerebral circulation of man. J Pharmacol Exp Ther 1935, 53: 113.
Ledo AAP: Spreading depression of activity in cerebral cortex. J Neurophysiol 1944, 7: 359–390.
Lashley KS: Patterns of cerebral integration indicated by scotomas of migraine. Arch Neurol Psychiat 1941, 46: 331.
Lauritzen M, Olesen J: Regional cerebral blood flow during migraine attacks by Xenon-133 inhalation and emission tomography. Brain 1984, 107: 447–461.
Olesen J, Friberg L, Olsen TS, et al.: Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990, 28:791–798.
Cutrer FM, Sorensen AG, Weisskoff RM, et al.: Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol 1998, 43:25–31.
Woods RP, Iacoboni M, Mazziotta JC: Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994, 331: 1689–1692.
Weiner C, May A, Limmroth V, et al.: Brain stem activation in spontaneous human migraine attacks. Nat Med 1995, 1:658–660.
Raskin NH, Hosobuchi Y, Lamb S: Headache may arise from perturbation of brain. Headache 1987, 27: 416–420.
Goadsby PJ, Edvinsson L, Ekman R: Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990, 28: 183–187.
Moskowitz MA: Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 1992, 13: 307–311.
Goadsby PJ, Zagami AS, Lambert GA: Neural processing of craniovascular pain: a synthesis of the central-structures involved in migraine. Headache 1991, 31: 365–371.
Schoenen REF: Contingent negative variation: methods and potential interest in headache. Cephalalgia 1993, 13 (1): 28–32.
tlfra J, Cecchini AP, DePasqua V, et al.: Visual evoked potentials during long periods of pattern-reversal stimulation in migraine. Brain 1998, 121:233–241.
Wang W, Lenaerts M, Schoenen J: Reduced habituation of pattern-reversal visual evoked responses in migraine. Paper presented at: International Conference of the European Headache Federation; June 1994; Liege, Belgium.
Welch KMA, Cao Y, Aurora S, et al.: MRI of the occipital cortex, red nucleus, and substantia nigra during visual aura of migraine. Neurology 1998, 51:1465–1469.
Joutel A, Bousser MG, Biousse V, et al.: A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet 1993, 5:40–45.
Ophoff RA, Terwindt GM, Vergouwe MN, et al.: Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Ce11 1996, 87:543–552.
Barbiroli B Montagna P, Cortelli P, et al.: Abnormal brain and muscle metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology 1992, 42:1209–1214.
Welch KM, Levine SR, D’Andrea G, et al.: Preliminary observation on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology 1989, 39:538–541.
Ferrari MD, Odink J, Tapparelli C, et al.: Serotonin metabolism in migraine. Neurology 1989, 39:1239–1242.
Humphrey PPA: 5-Hydroxytryptamine and the pathophysiology of migraine. J Neurol 1991, 238:S38–S44.
Ferrari MD: Systemic biochemistry. In The Headaches. Edited by Olesen J, Tfelt-Hansen P, Welch KMA. New York: Raven Press; 1993: 179–183.
Parsons AA, Whalley ET: Characterization of the 5-HT receptor which mediates contraction of the human isolated basilar artery. Cephalalgia 1989, 9 (S9): 47–51.
Fozard JR, Kalkman HO: 5-HT in nervous system disease and migraine. Curr Opin Neural Neurosurg 1992, 5 (4): 496–502.
Peroutka SJ: Antimigraine drug interactions with serotonin receptor subtypes in human brain. Ann Neural 1988, 23 (5): 500–504.
Peroutka SJ: Dopamine and migraine. Neurology 1997, 49 (3): 650–656.
Goadsby PJ: The pathophysiology of primary headache. In Headache in Clinical Practice. Edited by Silberstein SD, Lipton RB, Goadsby PJ. Oxford: ISIS Medical Media; 1998.
Storer RJ, Goadsby PJ: Trigeminovascular nociceptive transmission involves N-methyl-D-aspartate and non-N-methyl-D-aspartate glutamate receptors. Neuroscience 1999, 90 (4): 1371–1376.
Schoenen J, Sianard-Gainko J, Lenaerts M: Blood magnesium levels in migraine. Cephalalgia 1991, 11: 97–99.
Ramadan NM, Halvorson H, Vande-Linde A, et al. Low brain magnesium level in migraine. Headache 1989, 29 (7): 416–419.
Somerville BM: The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972, 22: 355–365.
Welch KMA, Darnley D, Simkins RT: The role of estrogens in migraine: a review and hypothesis. Cephalalgia 1984, 4: 227–236.
Mathew NT, Kailasam J, Meadors L, et al.: Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report. Headache 2000, 40(9):720–723.
Goadsby PJ, Hargreaves RJ: Mechanisms of action of serotonin 5-HT1B/D agonists: insights into migraine pathophysiology using rizatriptan. Neurology 2000, 55: S8 - S14.
Goadsby PJ: The scientific basis of medication choice in symptomatic migraine treatment. Can J Neurol Sci 1999, 26: 20–26.
Humphrey PP, Feniuk W: Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol Sci 1991, 12: 444–446.
Silberstein SD: Rizatriptan versus usual care in long-term treatment of migraine. Neurology 2000, 55: S25 - S28.
Solomon GD, Cady RK, Klapper JA, et al.: Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. Neurology 1997, 49:1219–1225.
Nappi G, Sicuteri F, Byrne M, et al.: Oral sumatriptan compared with placebo in the acute treatment of migraine. J Neurol 1994, 241:138–144.
Sargent J, Kirchner J, Davis R, Kirkhart B: Oral sumatriptan is effective and well tolerated for the acute treatment of migraine: results of a multicenter study. Neurology 1995, 45: S10 - S14.
Tfelt-Hansen P, Ryan RE Jr: Oral therapy for migraine: comparisons between rizatriptan and sumatriptan. A review of four randomized, double-blind clinical trials. Neurology 2000, 55: S19 - S24.
The International 311C90 Long-term Study Group: The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. Headache 1998, 38: 173–183.
Cady RK, Lipton RB, Hall C, et al.: Treatment of mild headache in disabled migraine sufferers: results of the Spectrum Study. Headache 2000, 40(10):792–797.
Lipton RB, Stewart WF, Cady R, et al.: Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. Headache 2000, 40(10):1–9.
Raskin NH: Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 1986, 36 (7): 995–997.
Goadsby PJ: How do the currently used prophylactic agents work in migraine? Cephalalgia 1997, 17: 85–92.
Breslau N, Merikangas K, Bowden CL: Comorbidity of migraine and major affective disorders. Neurology 1994, 44: S17 - S22.
Breslau N, Davis GC, Schultz LR, Peterson EL: Migraine and major depression: a longitudinal study. Headache 1994, 34: 387–393.
Schoenen J, Jacquy J, Lenaerts M: Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 1998, 50: 466–470.
Silberstein SD, Silberstein MM: New concepts in the pathogenesis of headache: migraine versus tension-type headache. Phys Assist 1991, 9: 67–81.
Jensen R, Olesen J: Initiating mechanisms of experimentally-induced tension-type headache. Cephalalgia 1996, 16: 175.
Schoenen J, Sandor P: Headache. In Textbook of Pain, edn 4. Edited by Wall PD, Melzack R. New York: Churchill Livingstone; 1999.
Lance JW, Ekbom K: In Cluster Headaches: Mechanism and Management. Edited by Kudrow L. New York: Oxford University Press; 1980: 27–28.
Hardebo JE: On pain mechanisms in cluster headache. Headache 1991, 31: 91–106.
May A, Bahra A, Büchel, et al.: PET and MRA findings in cluster headache and MRA in experimental pain. Neurology 2000, 55:1328–1335.
Lenaerts M, Couch JR: Trigeminal neuralgia. Emedicine [serial online]. 2001. Available at: http://www.emedicine.com/oph/NEUROLOGIC_DISORDERS.htm. Accessed January 25, 2001.
Blom S: Trigeminal neuralgia: a treatment with a new anticonvulsant drug. Lancet 1962, 1: 839–840.
Fromm GH, Terrence CF, Chattha AS: Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol 1984, 15 (3): 240–244.
McLaughlin MR, Jannetta PJ, Clyde BL, et al.: Microvascular decompression of cranial nerves: lessons learned after 4400 operations. J Neurosurg 1999, 90(1):1–8.
Evans RW, Armon C, Frohman EM, Goodin DS: Assessment: prevention of post-lumbar puncture headaches: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 2000, 55: 909–914.
Lenaerts M, Pepin JL, Tombu S, Schoenen J: No significant effect of an “atraumatic” needle on the incidence of post-lumbar puncture headache or traumatic tap. Cephalalgia 1993, 13: 296–297.
Williams E, Fawcett W, Jenkins G: Preventing headache after lumbar puncture. Optimism generally quoted for epidural blood patching is unwarranted. BMJ 1998, 317: 1588–1589.
Panagopoulos G, Gotsi A, Piaditis G, et al.: Treatment of benign intracranial hypertension with octreotide [abstract]. American Academy of Neurology. 1998.
Lou L: Uncommon areas of electrical stimulation for pain relief. Curr Rev Pain 2000, 4 (5): 407–412.
Weiner RL: The future of peripheral nerve neurostimulation. Neurol Res 2000, 22: 299–303.
Sjaastad O, Saunte C, Hovdahl H, et al.: “Cervicogenic” headache: a hypothesis. Cephalalgia 1983, 3(4):249–256
Sjaastad O, Fredriksen TA, Pfaffenrath V: Cervicogenic headache: diagnostic criteria. Headache 1990, 30: 725–726.
Dalessio JD: In Wolfs Headache and Other Head Pain, edn 3. Edited by Dalessio JD, Silberstein SD. New York: Oxford University Press; 1972: 71.
Tournier-Lasserve E, Joutel A, Melki J, et al.: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19g12. Nat Genet 1993, 3:256–259.
Day JW, Raskin NH: Thunderclap headache: symptom of unruptured cerebral aneurysm. Lancet 1986, 2: 1247–1248.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Lenaerts, M.E., Couch, J.R. (2003). Headache. In: Rosenberg, R.N. (eds) Atlas of Clinical Neurology. Current Medicine Group, London. https://doi.org/10.1007/978-1-4757-4552-8_15
Download citation
DOI: https://doi.org/10.1007/978-1-4757-4552-8_15
Publisher Name: Current Medicine Group, London
Print ISBN: 978-1-4757-4554-2
Online ISBN: 978-1-4757-4552-8
eBook Packages: Springer Book Archive